Can a Dual-Chamber heart pump save the failing heart?

NCT ID NCT07757451

First seen Aug 11, 2026 · Last updated Aug 12, 2026 · Updated 1 time

Summary

This trial is testing a new mechanical heart pump called the DuoCor 2, designed to support both sides of the heart in people with advanced heart failure. The study will enroll 64 patients who are severely ill and need circulatory support. The main goal is to see if the device helps patients survive without major complications for at least six months, with follow-up for up to two years. The trial also measures improvements in patients' ability to walk and their overall heart function.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
DuoCor 2 Ventricular Assist System (a mechanical heart pump implanted to support both sides of the heart)
What this could lead to
If successful, this device could offer a new lifeline for people with advanced heart failure, potentially improving survival and quality of life while waiting for a transplant or as a long-term support.
What could go wrong
This is an early-stage, single-arm study with a small number of participants. The device is invasive and carries risks like bleeding, infection, or device malfunction. Success is not guaranteed, and results may not apply to all patients.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ADVANCED HEART FAILURE are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Union Hospital Tongji Medical College Huazhong University of Science and Technology

    Wuhan, Hubei, 430000, China

More trials for these conditions

Other studies related to the condition(s) this trial covers.